Design Therapeutics to Participate in Leerink's Global Healthcare Conference

GlobeNewswireMar 3 08:00 ET

RBC: The first half of the year is expected to welcome positive catalysts. COMPASS Pathways (CMPS.US) and 12 other mid-small pharmaceutical stocks are worth a look.

RBC believes that some important catalysts for small and mid-cap Biotechnology companies in the first quarter of 2025 may have a significant impact on the Stocks it covers.

Zhitong FinanceFeb 26 03:36 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaJan 21 07:07 ET

Design Therapeutics Updates Corporate Presentation for Investors

TipRanksJan 13 09:32 ET

Despite Design Therapeutics' Pullback, Insiders Still Gained US$39k

Simply Wall StJan 9 05:00 ET

Solid Biosciences Stock Jumps 11% Post-market on FDA Update

Seeking AlphaJan 7 17:23 ET